These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 151470)
1. Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systems. Collen D Acta Clin Belg; 1977; 32(6):398-402. PubMed ID: 151470 [No Abstract] [Full Text] [Related]
2. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma. Collen D Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714 [No Abstract] [Full Text] [Related]
3. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609 [TBL] [Abstract][Full Text] [Related]
4. Placental protein 5 is related to blood coagulation and fibrinolytic systems. Siiteri JE; Koistinen R; Salem HT; Bohn H; Seppälä M Life Sci; 1982 May; 30(22):1885-91. PubMed ID: 6213827 [TBL] [Abstract][Full Text] [Related]
5. Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin. Foley JH; Walton BL; Aleman MM; O'Byrne AM; Lei V; Harrasser M; Foley KA; Wolberg AS; Conway EM EBioMedicine; 2016 Mar; 5():175-82. PubMed ID: 27077125 [TBL] [Abstract][Full Text] [Related]
6. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102 [TBL] [Abstract][Full Text] [Related]
7. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio. Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223 [TBL] [Abstract][Full Text] [Related]
9. Neoantigenic expression in enzyme-inhibitor complexes. A means to demonstrate activation of enzyme systems. Collen D; de Cock F Biochim Biophys Acta; 1978 Jul; 525(1):287-90. PubMed ID: 150860 [TBL] [Abstract][Full Text] [Related]
10. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome. Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425 [TBL] [Abstract][Full Text] [Related]
11. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon]. Ohsato K; Okamoto K Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885 [TBL] [Abstract][Full Text] [Related]
12. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842 [TBL] [Abstract][Full Text] [Related]
13. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants? Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263 [TBL] [Abstract][Full Text] [Related]
14. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex. Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845 [TBL] [Abstract][Full Text] [Related]
15. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders]. Bokarev IN; Butorov VN; Loginov LE Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714 [No Abstract] [Full Text] [Related]
16. Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication. Handa K; Takao M; Nomoto J; Oku K; Shirai K; Saku K; Arakawa K Angiology; 1996 Jun; 47(6):543-8. PubMed ID: 8678328 [TBL] [Abstract][Full Text] [Related]
17. A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma. Collen D; De Cock F Thromb Res; 1975 Jul; 7(1):235-8. PubMed ID: 125465 [No Abstract] [Full Text] [Related]
18. Emergence in plasma during activation of the coagulation or fibrinolytic systems of neoantigens, associated with the complexes of thrombin or plasmin with their inhibitors. Collen D Thromb Res; 1974 Dec; 5(6):777-9. PubMed ID: 4280636 [No Abstract] [Full Text] [Related]
19. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Levi M; de Boer JP; Roem D; ten Cate JW; Hack CE Thromb Haemost; 1992 Jan; 67(1):111-6. PubMed ID: 1377412 [TBL] [Abstract][Full Text] [Related]
20. In vivo-generated thrombin and plasmin do not activate the complement system in baboons. Keshari RS; Silasi R; Lupu C; Taylor FB; Lupu F Blood; 2017 Dec; 130(24):2678-2681. PubMed ID: 29021229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]